Crumly & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Crumly & Associates's LLY Position: Q2 2026 in Review
Crumly & Associates increased its Eli Lilly (LLY) stake by 1% in Q2 2026, buying an estimated $8.17K and bringing the position to 793 shares worth $951K. The position accounts for 0.18% of the portfolio, ranked #79.
Crumly & Associates first reported a position in LLY in Q4 2020 and has held it in 14 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Crumly & Associates held 793 shares of Eli Lilly worth $951K as of Q2 2026.
- Crumly & Associates bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
- Eli Lilly made up 0.18% of Crumly & Associates's portfolio in Q2 2026, its #79 holding.
- Crumly & Associates first reported a position in Eli Lilly in Q4 2020 and has held it in 14 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Crumly & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.